Skip to main content
. 2017 Oct 10;29(1):e5. doi: 10.3802/jgo.2018.29.e5

Fig. 3.

Fig. 3

In the patients with LN metastasis, the 3-year DFS rate was 79.4%, the 5-year OS rate was 90.6%, and the 5-year DSS rate was 90.6%.

DFS, disease-free survival; DSS, disease-specific survival; LN, lymph node; OS, overall survival.